Erlotinib: prices and alternatives
Indicated for metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 (L858R) mutations. Also indicated as first-line treatment for locally advanced or metastatic pancreatic cancer in combination with gemcitabine.
3 products with this active ingredient from 2 manufacturers. Official prices from 10850 to 56140 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.


